Clinical Trial Update: RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating rifaximin for hepatic encephalopathy; trial terminated with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: University of Miami | Conditions: Hepatic Encephalopathy | Phase 3 | Status: TERMINATED | Results posted: 2019-09-17